Last reviewed · How we verify

NCT03904420

An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients

Terminated NA Results posted Last updated 29 October 2020
What this trial tests

NA trial testing Clinical Education and Treatment Model in Sensorineural Hearing Loss, Bilateral in 4 participants. Terminated before completion.

Timeline
26 February 2019
Primary endpoint
29 October 2019
29 October 2019

Quick facts

Lead sponsorCochlear
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment4
Start date26 February 2019
Primary completion29 October 2019
Estimated completion29 October 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cochlear — full company profile →

Who can join

18 and older, any sex, with Sensorineural Hearing Loss, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical investigation is evaluating a new clinical model in a group of newly implanted subjects who have already been consented to CI surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sensorineural Hearing Loss, Bilateral

Currently open trials in the same condition.

Other Cochlear trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03904420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing